Imidazole‐stabilized gold nanoparticles induce neuronal apoptosis: An in vitro and in vivo study. Issue 4 (2nd August 2014)
- Record Type:
- Journal Article
- Title:
- Imidazole‐stabilized gold nanoparticles induce neuronal apoptosis: An in vitro and in vivo study. Issue 4 (2nd August 2014)
- Main Title:
- Imidazole‐stabilized gold nanoparticles induce neuronal apoptosis: An in vitro and in vivo study
- Authors:
- Imperatore, Roberta
Carotenuto, Gianfranco
Di Grazia, Maria Antonietta
Ferrandino, Ida
Palomba, Letizia
Mariotti, Raffaella
Vitale, Emilia
De Nicola, Sergio
Longo, Angela
Cristino, Luigia - Abstract:
- <abstract abstract-type="main"> <title>Abstract</title> <p>Gold nanoparticles are increasingly being employed in innovative biological applications thanks to their advantages of material‐ and size‐dependent physics and chemical interactions with the cellular systems. On the other hand, growing concern has emerged on the toxicity which would render gold‐based nanoparticles harmful to cell cultures, animals, and humans. Emerging attention is focused on the interaction of gold nanoparticles with nervous system, especially regarding the ability to overcome the blood–brain barrier (BBB) which represents the major impediment to the delivery of therapeutics into the brain. We synthesized highly stable 2‐mercapto‐1‐methylimidazole‐stabilized gold‐nanoparticles (AuNPs)‐mmi to investigate their entry, accumulation, and toxicity in vitro (SH‐SY5Y human neuroblastoma cells) and in vivo (brain of C57BL/6 mice) through optical and electron microscopy. After incubation in the cell culture medium at the lowest dose of 0.1 mg/mL the (AuNPs)‐mmi nanoparticles were found compacted and recruited into endosome/lysosomes (1 h) before their fusion (2 h) and the onset of neuronal death by apoptosis (4 h) as proved by terminal‐transferase‐mediated dUTP nick end labeling assay and caspase‐3 immunoreactivity. The ability of (AuNPs)‐mmi to cross the BBB was assessed by injection in the caudal vein of C57BL/6 mice. Among different brain regions, the nanoparticles were found in the CaudatoPutamen area,<abstract abstract-type="main"> <title>Abstract</title> <p>Gold nanoparticles are increasingly being employed in innovative biological applications thanks to their advantages of material‐ and size‐dependent physics and chemical interactions with the cellular systems. On the other hand, growing concern has emerged on the toxicity which would render gold‐based nanoparticles harmful to cell cultures, animals, and humans. Emerging attention is focused on the interaction of gold nanoparticles with nervous system, especially regarding the ability to overcome the blood–brain barrier (BBB) which represents the major impediment to the delivery of therapeutics into the brain. We synthesized highly stable 2‐mercapto‐1‐methylimidazole‐stabilized gold‐nanoparticles (AuNPs)‐mmi to investigate their entry, accumulation, and toxicity in vitro (SH‐SY5Y human neuroblastoma cells) and in vivo (brain of C57BL/6 mice) through optical and electron microscopy. After incubation in the cell culture medium at the lowest dose of 0.1 mg/mL the (AuNPs)‐mmi nanoparticles were found compacted and recruited into endosome/lysosomes (1 h) before their fusion (2 h) and the onset of neuronal death by apoptosis (4 h) as proved by terminal‐transferase‐mediated dUTP nick end labeling assay and caspase‐3 immunoreactivity. The ability of (AuNPs)‐mmi to cross the BBB was assessed by injection in the caudal vein of C57BL/6 mice. Among different brain regions, the nanoparticles were found in the CaudatoPutamen area, mainly in the striatal neurons 4 h after injection. These neurons showed the typical hallmarks of apoptosis. Our findings provide, for the first time, the dynamic of 2‐mercapto‐1‐methylimidazole nanogold uptake. The molecular mechanism which underlies the nanogold‐driven apoptotic event is analyzed and discussed in order to take into account when designing nanomaterials to interface with biological structures. © 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1436–1446, 2015.</p> </abstract> … (more)
- Is Part Of:
- Journal of biomedical materials research. Volume 103:Issue 4(2015:Apr.)
- Journal:
- Journal of biomedical materials research
- Issue:
- Volume 103:Issue 4(2015:Apr.)
- Issue Display:
- Volume 103, Issue 4 (2015)
- Year:
- 2015
- Volume:
- 103
- Issue:
- 4
- Issue Sort Value:
- 2015-0103-0004-0000
- Page Start:
- 1436
- Page End:
- 1446
- Publication Date:
- 2014-08-02
- Subjects:
- Biomedical materials -- Periodicals
610.28 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1552-4965 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/jbm.a.35289 ↗
- Languages:
- English
- ISSNs:
- 1549-3296
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4953.720000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3518.xml